M
46
6
O
20
-6
MDLZ
30
2
ACN
50
-6
AMG
49
14
WFC
60
2
AIV
37
-3
DHI
27
-9
CNP
52
-7
HAL
30
-10
MO
44
-3
GS
55
-10
CSCO
66
3
JWN
60
-9
BLK
50
3
ADT
25
11
FFIV
63
2
PCG
61
2
EXR
31
-11
GME
63
2
M
46
6
O
20
-6
MDLZ
30
2
ACN
50
-6
AMG
49
14
WFC
60
2
AIV
37
-3
DHI
27
-9
CNP
52
-7
HAL
30
-10
MO
44
-3
GS
55
-10
CSCO
66
3
JWN
60
-9
BLK
50
3
ADT
25
11
FFIV
63
2
PCG
61
2
EXR
31
-11
GME
63
2
Financhill
Back

Calidi Biotherapeutics 10K Form

Sell
4

CLDI
Calidi Biotherapeutics

Last Price:
$1.44
Seasonality Move:
-22.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLDI News And Ratings

See the #1 stock for the next 7 days that we like better than CLDI

CLDI Financial Statistics

Sales & Book Value

Annual Sales: $45K
Cash Flow: $-5M
Price / Cash Flow: 0
Annual Sales: $-1.10
Price / Book: 0

Profitability

EPS (TTM): -18.96660
Net Income (TTM): $-26.3M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Calidi Biotherapeutics Earnings Forecast

Key Calidi Biotherapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for CLDI have been equal to 35,337.78% of Gross Profit Margin.
  • The Interest Expense is -3.66% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

Calidi Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLDI
Website: calidibio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLDI Technical Analysis vs Fundamental Analysis

Sell
4
Calidi Biotherapeutics (CLDI) is a Sell

Is Calidi Biotherapeutics a Buy or a Sell?